Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, contro... by Vianney Tricou, Brandon Essink, John E Ervin, Mark Turner, Ian Escudero, Martina Rauscher, Manja Brose, Inge Lefevre, Astrid Borkowski, Derek Wallace

Connect to this object online.

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind tri... by Pio López, Eduardo López-Medina, Xavier Sáez-Llorens, Rodrigo deAntonio, Taisei Masuda, Paul M. Mendelman, James Sherwood, Frank Baehner, Astrid Borkowski

Connect to this object online.

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial by Mark Turner, Athanasia Papadimitriou, Peter Winkle, Nathan Segall, Michael Levin, Matthew Doust, Casey Johnson, Gregg Lucksinger, Carlos Fierro, Paul Pickrell, Marsha Raanan, Vianney Tricou, Astrid Borkowski, Derek Wallace

Connect to this object online.

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City by Shibadas Biswal, Jorge Fernando Mendez Galvan, Mercedes Macias Parra, Juan-Francisco, Monica Belisa Carrascal Rodriguez, Esteban Patricio Rodriguez Bueno, Manja Brose, Martina Rauscher, Inge LeFevre, Derek Wallace, Astrid Borkowski

Connect to this object online.